MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Eligible age
18–80 yrs
Accepts
All genders
Locations
15 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated balloon in treatment of small vessels (≤2.75 mm). A total of 1605 subjects will be enrolled in a maximum of 50 study sites located in North America. Additional sites located in Europe and South America may also participate in the study, with non-US sites contributing a maximum of \~50% of enrollees.
Sponsor: Concept Medical Inc.
Where it's recruiting
Gilbert
Los Angeles
Clearwater · Jacksonville · Tallahassee · Tampa
Atlanta · Decatur
Maywood
Tupelo
Pomona
Brooklyn · Manhasset · New York · The Bronx
Raleigh
Cleveland
Oklahoma City
Portland
Source: ClinicalTrials.gov · NCT06271590 · last updated 2025-09-11